SBIR/STTR Research Award

Cellular regeneration in the organ of Corti

Award identifier 8ebea7752aa0fa6fa530c094e76dc45f38ac8a393d3d04f3b11e9c8fb3764e3fAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$160,000

Program and phase

SBIR · Phase I

Award year

2003

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Sound Pharmaceuticals Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
S8Q8EVXYLSN1
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Sensorineuronal hearing loss affects millions of people worldwide and in the U.S. Loss of the sensory hair cell in the organ of Corti is thought to be a major cause of this deficit. In animals that are capable of regenerating their hair cells after hair cell death or loss (e.g. birds), a key first step is I the renewed proliferative capacity of the non-sensory supporting cell. In birds, supporting cell proliferation gives rise to new functioning hair cells after acoustic trauma or aminoglycoside poisoning. Unfortunately, supporting cell proliferation in the mammalian organ of Corti has never been observed either after hair cell death or the addition of growth factors. The cyclin-dependent kinase inhibitor, p27Kip1, is expressed in the supporting cells of mice from birth through adulthood. Genetic deletion of p27Kip1 results in continued supporting cell proliferation after birth and into adulthood. Deletion of p27Kip1 in mice is sufficient to induce low levels of hair cell regeneration following drug-induced hair cell death. In addition, reduction of p27Kip1 levels by lipofection of antisense oligonucleotides specific to p27Kip1, can induce supporting cell proliferation in vitro and in vivo. This proliferation appears to be limited by the poor efficiency of transfection of supporting cells by lipofection reagents. We propose to compare lipofection of p27Kip1 antisense oligonucleotides to that achieved by recombinant adeno-associated virus. The most effective and least ototoxic AAV subtype will be utilized to transfect mouse organ of Corti explant cultures with a p27Kip1 antisense expression cassette or a p27Kip1 ribozyme expression cassette. The expression cassettes for p27Kip1 antisense and ribozyme will be optimized in cell lines prior to their use on explant cultures. This will facilitate the development of pharmacologic means to improve and restore hearing through regeneration of sensory cells in the cochlea over that which has been observed with antisense oligonucleotides.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.